Longhorn Vaccines and Diagnostics Partners with Promega to Combine Complementary Offerings for Enhanced Sample Collection, Transport and Analysis

Previous
Previous

Longhorn Vaccines and Diagnostics to Present Late-Breaking Poster at ESCMID 2025 on LHNVD-303 to Treat and Prevent Antimicrobial Resistance

Next
Next

Longhorn Vaccines and Diagnostics Validates Efficacy of PrimeStore® Molecular Transport Medium (MTM) to Inactivate Deadly Pathogens